Pathogenetix, Inc. logo — Harnessing advanced genomics for speedy, cost-effective path...

Pathogenetix, Inc.

Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.

Founded 1997 6 employees Series C Total: $28.37M Biotechnology, Health Care

General Information

Company Name Pathogenetix, Inc.
Founded Year 1997
Employees 6
Industries Biotechnology, Health Care
Funding Stage Series C
Social

Get notified when Pathogenetix, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pathogenetix, Inc.

Pathogenetix, Inc. is a biotechnology startup dedicated to revolutionizing pathogen detection across various industries. The company's slogan, "Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics," reflects their core mission. Founded in 1997, Pathogenetix has developed an automated system utilizing Genome Sequence Scanning Technology to swiftly identify harmful bacterial strains. Their innovative method, involving a single reagent set to produce genomic barcodes from bacterial DNA, enables the cost-effective identification of thousands of strains within three hours. The company's GSS platform is poised to address applications in genomics research, food and product safety testing, and clinical infectious disease diagnostics. Notably, their Series C investment of $10.00M on 30 October 2013 saw participation from prominent firms including Ascension Ventures, Excel Venture Management, and HealthCare Ventures. With plans for an initial commercial launch in the research market in 2012, Pathogenetix is positioned to make a significant impact in the field of pathogen detection and genome sequencing.

Taxonomy: genomics, pathogen detection, bacterial strains, genome sequencing, food safety, clinical diagnostics, automated system, proprietary technology, product safety testing, infectious disease diagnostics, GSS platform, rapid identification, DNA barcoding, commercial launch

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 3
Investor Investor Investor
30 Oct 2013
Series B •••••• 4
Investor Investor Investor
•••• ••••
01 Nov 2011
Series B •••••• 3
Investor Investor
•••• ••••
01 Aug 2011
Venture Round •••••• - 13 Dec 2010
Debt Financing •••••• - 19 Jan 2010

View All 6 Funding Rounds

Pathogenetix, Inc. Alternatives & Competitors

Pathogenetix, Inc. vs

Accelerating diagnostics to save limbs and lives, enabling real-time epidemiological insights for he...

Seed
Biotechnology, Health Care
Pathogenetix, Inc. vs

OTCQB: ZIVO. ZIVO Bioscience, Inc., is a research and development company with an intellectual prope...

Post Ipo Debt
11 employees
Biopharma, Biotechnology
Pathogenetix, Inc. vs
Servatus Ltd
Servatus Ltd Australia

Developing novel microbiome-based treatments for autoimmune diseases, including rheumatoid arthritis...

24 employees

FAQ About Pathogenetix, Inc.

Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.
Pathogenetix, Inc. was founded in 1997.
Pathogenetix, Inc. operates in the following industries: Biotechnology, Health Care.
Pathogenetix, Inc. has approximately 6 employees.
Pathogenetix, Inc. has completed 6 funding rounds, raising a total of $28.37M. The latest funding stage is Series C.
Top alternatives and competitors to Pathogenetix, Inc. include BioNanovations, ZIVO Bioscience, Inc., Servatus Ltd, SURI BioTech, Vectron Biosolutions AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pathogenetix, Inc. and BioNanovations are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pathogenetix, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy